Gerrits, T.; Brouwer, I.J.; Dijkstra, K.L.; Wolterbeek, R.; Bruijn, J.A.; Scharpfenecker, M.; Baelde, H.J.
Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease. Int. J. Mol. Sci. 2023, 24, 646.
https://doi.org/10.3390/ijms24010646
AMA Style
Gerrits T, Brouwer IJ, Dijkstra KL, Wolterbeek R, Bruijn JA, Scharpfenecker M, Baelde HJ.
Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease. International Journal of Molecular Sciences. 2023; 24(1):646.
https://doi.org/10.3390/ijms24010646
Chicago/Turabian Style
Gerrits, Tessa, Isabella J. Brouwer, Kyra L. Dijkstra, Ron Wolterbeek, Jan A. Bruijn, Marion Scharpfenecker, and Hans J. Baelde.
2023. "Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease" International Journal of Molecular Sciences 24, no. 1: 646.
https://doi.org/10.3390/ijms24010646
APA Style
Gerrits, T., Brouwer, I. J., Dijkstra, K. L., Wolterbeek, R., Bruijn, J. A., Scharpfenecker, M., & Baelde, H. J.
(2023). Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease. International Journal of Molecular Sciences, 24(1), 646.
https://doi.org/10.3390/ijms24010646